BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Partridge M, Yamamoto T, Grau C, Høyer M, Muren LP. Imaging of normal lung, liver and parotid gland function for radiotherapy. Acta Oncol 2010;49:997-1011. [PMID: 20831488 DOI: 10.3109/0284186X.2010.504735] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Fode MM, Bak-Fredslund K, Petersen JB, Worm E, Sørensen M, Høyer M. A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[18F]fluoro-2-deoxy-d-galactose. Acta Oncol 2017;56:1614-20. [PMID: 28849688 DOI: 10.1080/0284186X.2017.1366051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Clark HD, Moiseenko VV, Rackley TP, Thomas SD, Wu JS, Reinsberg SA. Development of a method for functional aspect identification in parotid using dynamic contrast-enhanced magnetic resonance imaging and concurrent stimulation. Acta Oncol 2015;54:1686-90. [PMID: 26252349 DOI: 10.3109/0284186X.2015.1067718] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
3 Møller DS, Khalil AA, Knap MM, Muren LP, Hoffmann L. A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients. Acta Oncol 2011;50:883-8. [PMID: 21767188 DOI: 10.3109/0284186X.2011.581694] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
4 Schmidt MA, Payne GS. Radiotherapy planning using MRI. Phys Med Biol 2015;60:R323-61. [PMID: 26509844 DOI: 10.1088/0031-9155/60/22/R323] [Cited by in Crossref: 177] [Cited by in F6Publishing: 69] [Article Influence: 25.3] [Reference Citation Analysis]
5 Holgersson G, Hoye E, Bergqvist M, Ekman S, Nyman J, Helsing M, Friesland S, Holgersson M, Ekberg L, Blystad T, Ewers SB, Mörth C, Löden B, Henriksson R, Bergström S. Swedish Lung Cancer Radiation Study Group: predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancer. Acta Oncol 2012;51:759-67. [PMID: 22793039 DOI: 10.3109/0284186X.2012.681064] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Partridge M, Powell C, Koopman M, Humbert Vidan L, Newbold K. Technical note: 9-month repositioning accuracy for functional response assessment in head and neck chemoradiotherapy. Br J Radiol 2012;85:1576-80. [PMID: 23175480 DOI: 10.1259/bjr/47081873] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Nyeng TB, Kallehauge JF, Høyer M, Petersen JB, Poulsen PR, Muren LP. Clinical validation of a 4D-CT based method for lung ventilation measurement in phantoms and patients. Acta Oncol 2011;50:897-907. [PMID: 21767190 DOI: 10.3109/0284186X.2011.577096] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
8 Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes. Acta Oncol 2013;52:910-8. [PMID: 23106174 DOI: 10.3109/0284186X.2012.731525] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
9 De Ruysscher D, Sharifi H, Defraene G, Kerns SL, Christiaens M, De Ruyck K, Peeters S, Vansteenkiste J, Jeraj R, Van Den Heuvel F, van Elmpt W. Quantification of radiation-induced lung damage with CT scans: the possible benefit for radiogenomics. Acta Oncol 2013;52:1405-10. [PMID: 23957564 DOI: 10.3109/0284186X.2013.813074] [Cited by in Crossref: 39] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
10 Farr KP, Møller DS, Khalil AA, Kramer S, Morsing A, Grau C. Loss of lung function after chemo-radiotherapy for NSCLC measured by perfusion SPECT/CT: Correlation with radiation dose and clinical morbidity. Acta Oncol 2015;54:1350-4. [PMID: 26203930 DOI: 10.3109/0284186X.2015.1061695] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
11 Zhou P, Zhang Y, Zhang Q, Zhang G, Yu H, Zhang S. Functional Liver Imaging in Radiotherapy for Liver Cancer: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:898435. [DOI: 10.3389/fonc.2022.898435] [Reference Citation Analysis]
12 Rosenberg L, Tepper J. Present and future innovations in radiation oncology. Surg Oncol Clin N Am 2013;22:599-618. [PMID: 23622082 DOI: 10.1016/j.soc.2013.02.007] [Reference Citation Analysis]
13 Høyer M, Muren LP. Stereotactic body radiation therapy--a discipline with Nordic origin and profile. Acta Oncol 2012;51:564-7. [PMID: 22574782 DOI: 10.3109/0284186X.2012.684869] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
14 Høyer M, Thor M, Thörnqvist S, Søndergaard J, Lassen-Ramshad Y, Paul Muren L. Advances in radiotherapy: from 2D to 4D. Cancer Imaging 2011;11 Spec No A:S147-52. [PMID: 22185864 DOI: 10.1102/1470-7330.2011.9036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
15 Ihalainen TM, Lönnroth NT, Peltonen JI, Uusi-Simola JK, Timonen MH, Kuusela LJ, Savolainen SE, Sipilä OE. MRI quality assurance using the ACR phantom in a multi-unit imaging center. Acta Oncol 2011;50:966-72. [PMID: 21767198 DOI: 10.3109/0284186X.2011.582515] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
16 Fode MM, Petersen JB, Sørensen M, Holt MI, Keiding S, Høyer M. 2-[18F]fluoro-2-deoxy-d-galactose positron emission tomography guided functional treatment planning of stereotactic body radiotherapy of liver tumours. Physics and Imaging in Radiation Oncology 2017;1:28-33. [DOI: 10.1016/j.phro.2017.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
17 Collan J, Kapanen M, Mäkitie A, Nyman H, Joensuu H, Tenhunen M, Saarilahti K. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival. Acta Oncol 2012;51:735-42. [PMID: 22150115 DOI: 10.3109/0284186X.2011.640348] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
18 Sørensen M, Fode MM, Petersen JB, Holt MI, Høyer M. Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F]FDGal PET/CT. Radiat Oncol 2021;16:192. [PMID: 34598730 DOI: 10.1186/s13014-021-01909-z] [Reference Citation Analysis]
19 Grau C, Høyer M, Alber M, Overgaard J, Lindegaard JC, Muren LP. Biology-guided adaptive radiotherapy (BiGART)--more than a vision? Acta Oncol 2013;52:1243-7. [PMID: 23984809 DOI: 10.3109/0284186X.2013.829245] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]